Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease and Abnormal Fractional Flow Reserve | Zendy

William F. Fearon | Zendy; David Shilane | Zendy; Nico H.J. Pijls | Zendy; Derek Boothroyd | Zendy; Pim A.L. Tonino | Zendy; Emanuele Barbato | Zendy; Peter Jüni | Zendy; Bernard De Bruyne | Zendy; Mark A. Hlatky | Zendy

Open Access

Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease and Abnormal Fractional Flow Reserve

Author(s) -

William F. Fearon,

David Shilane,

Nico H.J. Pijls,

Derek Boothroyd,

Pim A.L. Tonino,

Emanuele Barbato,

Peter Jüni,

Bernard De Bruyne,

Mark A. Hlatky

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.003059

Subject(s) - fractional flow reserve , medicine , conventional pci , percutaneous coronary intervention , cardiology , coronary artery disease , revascularization , angina , quality adjusted life year , coronary flow reserve , quality of life (healthcare) , cost effectiveness , myocardial infarction , coronary angiography , risk analysis (engineering) , nursing

The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 2 trial demonstrated a significant reduction in subsequent coronary revascularization among patients with stable angina and at least 1 coronary lesion with a fractional flow reserve ≤0.80 who were randomized to percutaneous coronary intervention (PCI) compared with best medical therapy. The economic and quality-of-life implications of PCI in the setting of an abnormal fractional flow reserve are unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research